Dimethadione-induced fetotoxicity in rats

Area of Science:

• Toxicology
• Developmental Biology
• Teratology

Background:

• Dimethadione is an anticonvulsant drug.
• Understanding its effects on fetal development is crucial for risk assessment.

Purpose of the Study:

• To evaluate the fetotoxic potential of dimethadione in a rat model.
• To determine dose-related effects and critical exposure periods during gestation.

Main Methods:

• Rats received oral dimethadione (0, 54, 433, 541 mg/kg) on days 1-21 or 6-15 of gestation.
• Maternal toxicity, fetal weight, mortality, and malformations were assessed.

Main Results:

• No maternal toxicity occurred with treatment on days 6-15. High doses (days 1-21) reduced maternal weight gain.
• Dimethadione caused dose-related decreases in fetal weight and increased incidences of umbilical hernia, edema, and ecchymoses.
• Skeletal anomalies included wavy ribs, extra ribs, delayed ossification, sternal defects, and limb bone malformations, increasing with dose.

Conclusions:

• Dimethadione exhibits significant fetotoxic potential in rats.
• Exposure during early gestation (days 1-21) resulted in more severe outcomes than later exposure (days 6-15).
• The study highlights the teratogenic risks associated with dimethadione exposure during pregnancy.